Harald Reinhart
CIK 1835824 · View on SEC EDGAR ↗
First SEC filing: Jan. 4, 2021 · Latest: Jan. 4, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 26, 2024 | ZLAB | S | 7,431 | $17.90 | $133,015 | 62,619 Direct | -10.61% | Disposed | 45.3% (price as of 2026-08-21) |
| April 4, 2024 | ZLAB | S | 2,105 | $15.67 | $32,985 | 51,800 Direct | -3.91% | Disposed | 66.0% (price as of 2026-08-21) |
| April 2, 2024 | ZLAB | S | 413 | $16.15 | $6,670 | 48,635 Direct | -0.84% | Disposed | 61.1% (price as of 2026-08-21) |
| April 2, 2024 | ZLAB | S | 1,360 | $16.15 | $21,964 | 49,048 Direct | -2.70% | Disposed | 61.1% (price as of 2026-08-21) |
| Jan. 3, 2024 | ZLAB | S | 4,803 | $26.12 | $125,454 | 46,060 Direct | -9.44% | Disposed | -0.4% (price as of 2026-08-21) |
| March 3, 2023 | ZLAB | S 10b5-1 | 11,480 | $40.00 | $459,200 | 18,958 Direct | -37.72% | Disposed | -35.0% (price as of 2026-08-21) |
| Nov. 15, 2022 | ZLAB | S 10b5-1 | 100 | $40.03 | $4,003 | 24,861 Direct | -0.40% | Disposed | -35.0% (price as of 2026-08-21) |
| Nov. 15, 2022 | ZLAB | S 10b5-1 | 1,754 | $40.00 | $70,160 | 24,961 Direct | -6.57% | Disposed | -35.0% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 25, 2024 | ZLAB | Restricted Share Units | American Depositary Shares [F1] (18,250) | — | — | 18,250 | Disposed |
| April 3, 2024 | ZLAB | Restricted Share Units | American Depositary Shares [F1] (5,270) | — | — | 5,270 | Disposed |
| April 1, 2024 | ZLAB | Restricted Share Units | American Depositary Shares [F1] (1,010) | — | — | 1,010 | Disposed |
| April 1, 2024 | ZLAB | Restricted Share Units | American Depositary Shares [F1] (3,338) | — | — | 3,338 | Disposed |
| April 1, 2024 | ZLAB | Restricted Share Units | American Depositary Shares [F1] (69,758) | — | — | 69,758 | Acquired |
| April 1, 2024 | ZLAB | Stock Options (Right to Buy) [F4] | American Depositary Shares [F1] (107,321) | $16.72 | April 1, 2034 | 107,321 | Acquired |
| Jan. 1, 2024 | ZLAB | Performance-Based Share Units | American Depositary Shares [F1] (17,548) | — | — | 17,548 | Disposed |
| Jan. 1, 2024 | ZLAB | Performance-Based Share Units | American Depositary Shares [F1] (17,548) | — | — | 17,548 | Acquired |
| June 23, 2023 | ZLAB | Restricted Share Units [F4] | American Depositary Shares [F1] (18,250) | $0.00 | — | 18,250 | Disposed |
| April 3, 2023 | ZLAB | Restricted Share Units | American Depositary Shares [F3] (21,081) | — | — | 21,081 | Acquired |
| April 3, 2023 | ZLAB | Stock Options (Right to Buy) | American Depositary Shares [F3] (109,632) | $33.95 | April 3, 2033 | 109,632 | Acquired |
| March 31, 2023 | ZLAB | Restricted Share Units | American Depositary Shares [F1] (1,010) | — | — | 1,010 | Disposed |
| March 31, 2023 | ZLAB | Restricted Share Units | American Depositary Shares [F1] (3,338) | — | — | 3,338 | Disposed |
| March 3, 2023 | ZLAB | Stock Options (Right to Buy) | American Depositary Shares (11,480) | $3.00 | May 12, 2027 | 11,480 | Disposed |
| Nov. 15, 2022 | ZLAB | Stock Options (Right to Buy) | American Depositary Shares (1,854) | $3.00 | May 12, 2027 | 1,854 | Disposed |
| June 25, 2022 | ZLAB | Restricted Share Units | American Depositary Shares (73,000) | — | — | 73,000 | Acquired |
| April 1, 2022 | ZLAB | Restricted Share Units | American Depositary Shares [F1] (1,010) | — | — | 1,010 | Disposed |
| April 1, 2022 | ZLAB | Restricted Share Units | American Depositary Shares [F1] (16,692) | — | — | 16,692 | Acquired |
| April 1, 2022 | ZLAB | Stock Options (Right to Buy) | American Depositary Shares [F1] (87,699) | $45.47 | April 1, 2032 | 87,699 | Acquired |
| April 1, 2021 | ZLAB | Restricted Share Units | Ordinary Shares (5,050) | — | — | 5,050 | Acquired |
| April 1, 2021 | ZLAB | Stock Options (Right to Buy) | Ordinary Shares (26,650) | $130.96 | April 1, 2031 | 26,650 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 4, 2021 | ZLAB | Stock Option (Right to Buy)→ Ordinary Shares | — | Direct |
| Jan. 4, 2021 | ZLAB | Stock Option (Right to Buy)→ Ordinary Shares | — | Direct |
| Jan. 4, 2021 | ZLAB | Stock Option (Right to Buy)→ Ordinary Shares (100,000) | 100,000 | Direct |
| Jan. 4, 2021 | ZLAB | Stock Option (Right to Buy)→ Ordinary Shares (50,000) | 50,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ZLAB
President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases.| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $466,090 | $107,640 | $5,238,208 | — | $264,960 | — | $7,250 | $8,212,040 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.